Skip to main content
Clinical Trials/NCT04534738
NCT04534738CompletedPhase 1

Diet And Nutrition In CAncer (The DANICA Study): The Effect of a Mediterranean Diet Intervention on Cancer-related Fatigue and Mitochondrial Function During Chemotherapy

University of Rochester2 sites in 1 country33 target enrollmentStarted: November 14, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
33
Locations
2
Primary Endpoint
The Number of Patients Who Enrolled Completed the Study.

Study Overview

Brief Summary

This study will assess the feasibility of delivering an 8-week Mediterranean Diet intervention as well as the intervention's preliminary efficacy on cancer-related fatigue among patients undergoing chemotherapy, compared to usual care. In the first 4 weeks of the intervention, we will provide the participants with food and educate them on the principles and components of the Mediterranean Diet, while in the second 4 weeks participants will prepare their own food. In addition, we will evaluate changes in metabolism and mitochondrial function during 4 weeks of chemotherapy and determine how adherence to a Mediterranean diet modulates these changes during these 4 weeks.

The hypothesis is that the intervention will promote adherence to the Mediterranean Diet. The second hypothesis is that adherence will be associated with alleviation of fatigue and improvements in metabolic and mitochondrial function.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •(Participants must...):
  • •Have a diagnosis of cancer,
  • •Be scheduled to receive chemotherapy and have at least 6 weeks remaining,
  • •Be able to speak English,
  • •Be willing to adhere to study procedures, and
  • •Be able to provide written informed consent.

Exclusion Criteria

  • •(Participants must not...):
  • •Be on enteral or parenteral nutrition,
  • •Be pregnant,
  • •Have distant metastases,
  • •Have a brain tumor,
  • •Have any plan to get radiation to the head,
  • •Have specific dietary needs that a Mediterranean diet cannot meet (e.g., allergies to nuts, gluten intolerance), or already be following the Mediterranean diet (i.e., have a score ≥10 on a modified 14-item Mediterranean Diet questionnaire).

Arms & Interventions

Mediterranean Diet

Experimental

Participants in the Mediterranean Diet arm are asked to follow a Mediterranean Diet for 8 weeks. The diet is ad libitum. A combination of fresh, frozen, and shelf-stable meals are provided for the first 4 weeks. Also during the first 4 weeks, participants receive an education session to discuss how to effectively implement a Mediterranean Diet into their daily routine.

Intervention: Mediterranean Diet (Behavioral)

Usual care

No Intervention

Participants in the usual care are will complete all the same study assessments as those in the intervention group. They will not receive any specific dietary advice, but they will be permitted to seek dietary advice outside the study. Data from this group are indispensable in understanding the nutritional habits and preferences of patients undergoing chemotherapy, and these data will be used to optimize nutritional interventions in future studies. At the end of the 8-week intervention, the participants in the usual care group will be provided the intervention materials gratis, including one-week of Mediterranean Diet food and education materials.

Outcomes

Primary Outcomes

The Number of Patients Who Enrolled Completed the Study.

Time Frame: 8 weeks

To assess feasibility of the study, we will report what percentage of patients who enrolled completed the study.

Scores From the 14-item Mediterranean Diet Questionnaire

Time Frame: 8 weeks

In order to assess adherence to the diet, we will report scores from the 14-item Mediterranean Diet questionnaire at 8 weeks. Scores range from 0 to 14 points. A higher score indicates greater adherence to the Mediterranean Diet.

Secondary Outcomes

  • The Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire(8 weeks)
  • The Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire, Fatigue Subscale(8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Luke Peppone

Associate Professor

University of Rochester

Study Sites (2)

Loading locations...

Similar Trials

The Effect of a Mediterranean Diet... | Clinical Trial